Compare Repligen Corporation Common Stock (RGEN) vs Zillow Group Inc Class C (Z) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Zillow Group Inc Class C — how do they compare? Repligen Corporation Common Stock trades at $178.85 (market cap $11.31B), while Zillow Group Inc Class C trades at $28.28 (market cap $6.42B). The key difference: Repligen Corporation Common Stock is the larger of the two by market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, Zillow Group Inc Class C nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Zillow Group Inc Class C for 39 Days on average.
| RGEN | Z | |
|---|---|---|
Market Cap | $11.31B | $6.42B |
Volume | 1,216,919 | 4,619,533 |
Sector | Health | Media |
52-Week High | $194.57 | $78.04 |
52-Week Low | $102.87 | $27.13 |
Typical Hold Time | 0 Days | 39 Days |
Enterprise Value | $11.20B | $6.29B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Zillow Group (Z) trades at $27.97, up 0.47% on the day, but remains in a bearish technical trend with weak moving averages. The company shows improving fundamentals with revenue growing from $2.2B in 2024 to $2.6B in 2025 and net income turning positive at $23M. Recent earnings show mixed results with Q1 and Q2 2026 beats but a Q4 2025 miss. The stock faces headwinds from elevated mortgage rates and housing market softness, though analyst consensus remains optimistic with a $52 price target.
Zillow presents a turnaround story with profitability improving but faces significant housing market risks. The stock trades at a premium valuation (P/E 123) despite modest margins, suggesting high growth expectations. Analyst sentiment is mixed with 46% buy ratings but technical indicators signal caution. Key catalysts include AI integration and rental platform expansion, while risks include mortgage rate sensitivity and competitive pressures from Compass.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Zillow Group Inc Class C
Zillow Group is an online real estate company that simplifies buying, selling, renting, and financing properties. It partners with agents, brokers, and landlords, combining technology with quality service. Its brands include Zillow, Trulia, StreetEasy, and Hotpads.
Read more on Z →
